Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT06951022

The Effect of Sujok Therapy on Urinary Incontinence and Quality of Life in Postmenopausal Women

This study aims to investigate the effect of Su Jok therapy, a complementary medicine practice, on urinary incontinence and quality of life among postmenopausal women. A total of 120 participants will be included in the study, with 60 in the intervention group and 60 in the control group. Participants in the intervention group will receive Su Jok seed therapy applied to the hand reflex points corresponding to the bladder. The therapy will be administered by the researcher and then taught to the participants, who will continue the application for 15 days. Assessments will be conducted at baseline, day 15, and day 30 using validated questionnaires.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Women under 65 years of age in the postmenopausal period, Literate, No speech or communication impairment

Exclusion criteria

Use of diuretics

Presence of nephrotic syndrome

Diagnosis of diabetes or hypertension

Symptoms of urinary tract infection

Diagnosis of psychiatric illness

History of urinary tract surgery

Diagnosed urinary prolapse

Failure to complete the intervention

Treatment and study plan

Sujok therapy

Other

Participants in the intervention group will receive seed therapy using apple seeds applied to specific hand points corresponding to the bladder area.

Primary outcomes

  1. Change in urinary incontinence symptoms measured by the International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF)

    Time frame: At baseline, 15 days and 30 days after intervention

    Description: The ICIQ-SF is a 4-item questionnaire used to evaluate the severity and impact of urinary incontinence.

    Scoring: Scores range from 0 to 21, with higher scores indicating more severe urinary incontinence.

    Unit of Measure: Points on a scale

  2. Change in quality of life measured by the Incontinence Quality of Life Scale (I-QOL)

    Time frame: At baseline, 15 days and 30 days after intervention

    Description: The I-QOL assesses quality of life, including behavioral limitation, psychosocial impact, and social isolation, in postmenopausal women with urinary incontinence.

    Scoring: Domain scores range from 0 to 100, where higher scores represent a poorer quality of life.

    Unit of Measure: Total score (0-100)

Sponsors and collaborators

Lead sponsor

Inonu University

Other

Registry information

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Apr 30, 2025
Registry last updated
Apr 30, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.